Company Filing History:
1 out of 79 
1 out of 8 
1 out of 20 
Years Active: 2018
Title: The Innovations of Gabriel Adrián Rabinovich
Introduction
Gabriel Adrián Rabinovich is a prominent inventor based in Buenos Aires, Argentina. He is known for his significant contributions to the field of immunology, particularly through his innovative work on Galectin-1 polypeptide variants. His research has implications for understanding and treating various medical conditions.
Latest Patents
Rabinovich holds a patent for "GAL-1 variants having immuno-modulating properties and methods of using the same." This patent describes Galectin-1 polypeptide variants that include a mutation of the histidine residue at position 52 of the full-length amino acid sequence of native human Gal-1. The mutation involves substituting histidine with tyrosine or asparagine, which provides resistance to acidosis that would otherwise deactivate native human Gal-1. Additionally, the variants may include mutations of the cysteine residue at positions 2, 16, or 88, with substitutions to serine, offering resistance to oxidation.
Career Highlights
Throughout his career, Rabinovich has worked with notable institutions, including the National Scientific and Technical Research Council (CONICET) and Fundación Sales. His research has been pivotal in advancing the understanding of immuno-modulation and its applications in medicine.
Collaborations
Rabinovich has collaborated with esteemed colleagues such as Santiago Di Lella and Dario Ariel Estrin. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Gabriel Adrián Rabinovich's work exemplifies the intersection of innovation and medical research. His patented inventions and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.